Fundraising FoxSCP Vitalife Partners
Venture capitalTel Aviv · Seed–Series B · 11 people tracked
Also known as SCP VITALIFE MANAGEMENT COMPANY, LLC
Find your way into SCP Vitalife Partners
Sign up to see every warm intro you have to SCP Vitalife Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SCP Vitalife Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
SCP Vitalife invests in life science startups in Israel and the U.S. that develop breakthrough products addressing current medical needs and protected by strong intellectual property. The firm has made more than 30 investments across two funds. Its team consists of professionals with experience as entrepreneurs, senior operating executives, clinical practitioners and technologists, and it provides hands-on support to portfolio companies by leveraging strategic partner relationships to help build successful businesses.
Source: firm website, verified Sep 29, 2026.
Team · 11 people
from the firm's website & public directories
What they invest in
from 11 of 19 portfolio companiesHealthtech ×7Medical Devices ×7Biotech ×6Robotics ×2Digital Health ×1EdTech ×1Enterprise Software ×1Media & Entertainment ×1
HQs:United States×5Israel×2
Investments · 19 tracked
founders shown can be your intro pathBy year:2026 · 12021 · 12020 · 12015 · 32014 · 17 dated
Lifeward develops products for physical rehabilitation and recovery, aimed at improving function and daily-life health for people with conditions such as spinal cord injury, brain injury, stroke, and multiple sclerosis.
BiotechHealthtechMedical DevicesRoboticsMarlborough, US
Charles Remsberg(Executive Officer)Larry Jasinski(Executive Officer, Director)Michael Lawless(Executive Officer)Almog Adar(Executive Officer)Jeannine Lynch(Executive Officer)inHadar Levy(Director)
Board seatWayne B. WeismanJeff Dykan· per SEC Form D · $8.8M raise · filed Jul 2020
Avedro is an ophthalmic company focused on corneal health, known for bio-activated cross-linking therapies such as the KXL system and riboflavin-based treatments used to address progressive keratoconus.
BiotechHealthtechMedical DevicesWaltham, US
David F. Muller(Executive Officer, Director)inBrian J. Roberts(Executive Officer)inRhonda J. Bracey(Executive Officer)inThomas W. Burns(Chairman & Chief Executive Officer)
BoardJason Hong(Director)
Board seatJeff Dykan· per SEC Form D
Co-investorsAPERTURE Venture PartnersLAVLilly Asia VenturesThird Point VenturesAbingworthBorealis Ventures+4 more
Echo360 provides learning engagement and analytics software to educational institutions and organizations.
EdTechEnterprise SoftwareSaaSReston, US
Frederick G.I. Singer(Executive Officer, Director)inAnthony Abate(Executive Officer)
BoardJon Patty(Director)Rohit K. Seth(Director)Evan Morgan(Director)Donn Davis(Director)in
Board seatWayne B. Weisman· per SEC Form D · $7.5M raise · filed Jan 2016
Co-investorsMultiplier Capitalo15 Capital PartnersRevolutionRunway Growth CapitalSWaN & Legend Venture Partners
Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors.
BiotechHealthtechMedical DevicesAmesbury, US
John Sokolowski(Executive Officer)inGeorge W. Gray(Executive Officer)Carolyn Malleck(Executive Officer)inJesse Ambrosina(Executive Officer)
BoardKetan Patel(Director)inJohn K. Clarke(Director)in
Board seatWayne B. Weisman· per SEC Form D
Co-investorsCardinal PartnersF-Prime CapitalECO Fleet HoldingsWuXi Healthcare Ventures
Specialty biopharmaceutical company developing differentiated prescription drugs for analgesia, anesthesia, sedation, and chronic pain management.
BiotechMalvern, US
Gerri A. Henwood(Executive Officer)
Board seatAbraham LudomirskiWayne B. WeismanWinston J. Churchill· per SEC Form D
Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform.
BiotechHealthtechMedical DevicesHerzliya, IL
Galit Reske(Executive Officer)Arie Gordashnikov(Executive Officer)Ori Gon(Executive Officer)in
BoardEhud Geller(Executive Officer, Director)Susan Alpert(Director)
Board seatJeff Dykan· per SEC Form D
Endospan develops endovascular stent graft systems, including the NEXUS Multi-Branch Aortic Arch Stent Graft System, for repairing aortic aneurysms and dissections in patients whose anatomy is unsuitable for traditional EVAR/TEVAR therapy.
HealthtechMedical Devices
Kevin Mayberry(Chief Executive Officer)inGadi Divald(Chief Financial Officer)
Co-investorsAccelmed Partners
Modern Systems Talk (MST) publishes content and insights on technology topics including system architecture, cloud computing, automation, AI, cybersecurity, and digital transformation.
Media & Entertainment
Co-investorsAgate Medical Investments LPForbionGV (Google Ventures)Northpond VenturesSV Health Investors
Lifeward (ReWalk) develops wearable exoskeletons and related products for physical rehabilitation and recovery, used in conditions such as spinal cord injury, brain injury, stroke, multiple sclerosis, and orthopedic/sports medicine.
HealthtechMedical DevicesRobotics
Co-investorsPontifax Venture Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
DIRDIR TechnologiesGarnet BioTherapeuticsLZ TherapeuticsnovoGIPocaredPocared DiagnosticsSensible Medical InnovationsSpine21
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
1 IPOs · 1 acquisitionsLifewardNASDAQ: LFWDAvedro, Inc.acq. by Glaukos
Portfolio news
latest coverage across their companies
Regentis · finance.yahoo.com · Aug 17, 2026
Sensible · trysignalbase.com · May 12, 2026
Ivenix · trysignalbase.com · Mar 25, 2026
Endospan · trysignalbase.com · Mar 25, 2026
Fund performance · per public LP disclosures · 3
as of Dec 2024| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| SCP Vitalife Partners II FundLPs: New York City Employees' Retirement System, New York City Police Pension Fund, New York City Fire Department Pension Fund | 2007 | — | -14.2% | 0.14x | 0.00x |
| SCP Vitalife Partners II, L.P.LPs: New York City Police Pension Fund, Teachers' Retirement System of the City of New York | 2007 | — | -17.7% | 0.07x | 0.07x |
| SCP Vitalife Partners Il FundLPs: New York City Fire Department Pension Fund | 2007 | — | -14.0% | 0.14x | 0.00x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- How many investments has SCP Vitalife Partners made?
- SCP Vitalife Partners has 19 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.
- What stage does SCP Vitalife Partners invest at?
- SCP Vitalife Partners invests at the Seed, Series A, Series B stages.
- What is SCP Vitalife Partners's typical check size?
- SCP Vitalife Partners typically writes checks of $3M – $7M.
- What sectors does SCP Vitalife Partners focus on?
- SCP Vitalife Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is SCP Vitalife Partners located?
- SCP Vitalife Partners is headquartered in Tel Aviv, IL.
- Who does SCP Vitalife Partners co-invest with?
- SCP Vitalife Partners most often shares deals with APERTURE Venture Partners, Cardinal Partners, F-Prime Capital, among 9 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.